 |
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
extracellular region
|
2 terms
|
 |
|
Biological process
|
mammary duct terminal end bud growth
|
22 terms
|
 |
|
Biochemical function
|
cytokine activity
|
2 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Biol Chem
273:22471-22479
(1998)
|
|
PubMed id:
|
|
|
|
|
| |
|
Solution structure of eotaxin, a chemokine that selectively recruits eosinophils in allergic inflammation.
|
|
M.P.Crump,
K.Rajarathnam,
K.S.Kim,
I.Clark-Lewis,
B.D.Sykes.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The solution structure of the CCR3-specific chemokine, eotaxin, has been
determined by NMR spectroscopy. The quaternary structure of eotaxin was
investigated by ultracentrifugation and NMR, and it was found to be in
equilibrium between monomer and dimer under a wide range of conditions. At pH
</= 5 and low ionic strength, eotaxin was found to be predominantly a
monomer. The three-dimensional structure of the eotaxin monomer solved at pH 5.0
revealed that it has a typical chemokine fold, which includes a 3-stranded
beta-sheet and an overlying alpha-helix. Except for the N-terminal residues
(residues 1-8), the core of the protein is well defined. The eotaxin structure
is compared with the chemokines regulated upon activation, normal T-cell
expressed and secreted (RANTES) and monocyte chemoattractant protein-1 (MCP-1);
eotaxin binds only CC chemokine receptor CCR3, whereas RANTES binds many
receptors including CCR3, and MCP-1 binds a distinct receptor, CCR2. The RMSD of
the eotaxin ensemble of structures with the RANTES average minimized monomeric
subunit is 5.52 +/- 0.87 A over all backbone atoms and 1.14 +/- 0.09 A over
backbone atoms of residues 11-28 and 34-65. The most important difference
between the structures is in the N-terminal residues that are unstructured in
eotaxin but structured in RANTES and MCP-1. Several residues in the loop region
of RANTES show similar packing in eotaxin (residues 11-17). As the N-terminal
and loop regions have been shown to be critical for receptor binding and
signaling, this structure will be useful for determining the basis for CCR3
selectivity of the eotaxin.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 4.
Fig. 4. Ensemble and average minimized structure of
eotaxin. A, superimposition of the 32 simulated annealing
structures of eotaxin on the average structure. The average
structure was generated by averaging the coordinates of the 32
final eotaxin structures. The structures were overlaid on the
average structure using just the backbone N, C , and C
atoms of residues 9-68. B, in an orientation that optimizes
clarity, the heavy atoms of well ordered side chains are labeled
and superimposed on the average structure. The N and C termini
are omitted for clarity. C, in the same orientation, a schematic
diagram showing the restrained minimized average structure of
eotaxin created with the program MOLSCRIPT (38). In this
representation the helix is represented as a flat ribbon and the
sheet with a broad arrow. The loops and turns are represented by
a slim ribbon.
|
 |
Figure 5.
Fig. 5. A, comparison of the tertiary structures of
eotaxin, RANTES, and MCP-1. The minimized mean structure of one
monomeric unit of both RANTES (blue, protein data base accession
code 1RTO) and MCP-1 (yellow, protein data base accession code
1DOM) was used for overlaying on eotaxin (red). Backbone heavy
atoms of the eotaxin minimized average structure excluding the N
terminus and disulfides (residues 1-10) and the 30-s turn
(residues 31-34) superimposed on MCP-1 (residues 13-32 and
37-69) with an RMSD of 1.29 Å. RANTES contains one less
residue between the first -strand and
the 30-s turn so eotaxin (residues 11-28 and 34-65) was
superimposed on the minimized average monomeric subunit of
RANTES (residues 12-29 and 34-65) giving an RMSD of 1.19
Å. B, comparison of ensembles of structures between RANTES
dimer and eotaxin monomer.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(1998,
273,
22471-22479)
copyright 1998.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
L.S.Simpson,
J.Z.Zhu,
T.S.Widlanski,
and
M.J.Stone
(2009).
Regulation of chemokine recognition by site-specific tyrosine sulfation of receptor peptides.
|
| |
Chem Biol, 16,
153-161.
|
 |
|
|
|
|
 |
E.L.Wise,
C.Duchesnes,
P.C.da Fonseca,
R.A.Allen,
T.J.Williams,
and
J.E.Pease
(2007).
Small molecule receptor agonists and antagonists of CCR3 provide insight into mechanisms of chemokine receptor activation.
|
| |
J Biol Chem, 282,
27935-27943.
|
 |
|
|
|
|
 |
S.J.Allen,
S.E.Crown,
and
T.M.Handel
(2007).
Chemokine: receptor structure, interactions, and antagonism.
|
| |
Annu Rev Immunol, 25,
787-820.
|
 |
|
|
|
|
 |
L.Rajagopalan,
and
K.Rajarathnam
(2006).
Structural basis of chemokine receptor function--a model for binding affinity and ligand selectivity.
|
| |
Biosci Rep, 26,
325-339.
|
 |
|
|
|
|
 |
J.Elsner,
S.E.Escher,
and
U.Forssmann
(2004).
Chemokine receptor antagonists: a novel therapeutic approach in allergic diseases.
|
| |
Allergy, 59,
1243-1258.
|
 |
|
|
|
|
 |
A.E.Proudfoot,
T.M.Handel,
Z.Johnson,
E.K.Lau,
P.LiWang,
I.Clark-Lewis,
F.Borlat,
T.N.Wells,
and
M.H.Kosco-Vilbois
(2003).
Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines.
|
| |
Proc Natl Acad Sci U S A, 100,
1885-1890.
|
 |
|
|
|
|
 |
K.L.Mayer,
and
M.J.Stone
(2003).
Backbone dynamics of the CC-chemokine eotaxin-2 and comparison among the eotaxin group chemokines.
|
| |
Proteins, 50,
184-191.
|
 |
|
|
|
|
 |
E.J.Fernandez,
and
E.Lolis
(2002).
Structure, function, and inhibition of chemokines.
|
| |
Annu Rev Pharmacol Toxicol, 42,
469-499.
|
 |
|
|
|
|
 |
B.T.Seet,
R.Singh,
C.Paavola,
E.K.Lau,
T.M.Handel,
and
G.McFadden
(2001).
Molecular determinants for CC-chemokine recognition by a poxvirus CC-chemokine inhibitor.
|
| |
Proc Natl Acad Sci U S A, 98,
9008-9013.
|
 |
|
|
|
|
 |
C.Baysal,
and
A.R.Atilgan
(2001).
Elucidating the structural mechanisms for biological activity of the chemokine family.
|
| |
Proteins, 43,
150-160.
|
 |
|
|
|
|
 |
T.S.Stantchev,
and
C.C.Broder
(2001).
Human immunodeficiency virus type-1 and chemokines: beyond competition for common cellular receptors.
|
| |
Cytokine Growth Factor Rev, 12,
219-243.
|
 |
|
|
|
|
 |
W.Shao,
E.Fernandez,
A.Sachpatzidis,
J.Wilken,
D.A.Thompson,
B.I.Schweitzer,
and
E.Lolis
(2001).
CCR2 and CCR5 receptor-binding properties of herpesvirus-8 vMIP-II based on sequence analysis and its solution structure.
|
| |
Eur J Biochem, 268,
2948-2959.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
Buyong,
J.Xiong,
J.Lubkowski,
and
R.Nussinov
(2000).
Homology modeling and molecular dynamics simulations of lymphotactin.
|
| |
Protein Sci, 9,
2192-2199.
|
 |
|
|
|
|
 |
E.J.Fernandez,
J.Wilken,
D.A.Thompson,
S.C.Peiper,
and
E.Lolis
(2000).
Comparison of the structure of vMIP-II with eotaxin-1, RANTES, and MCP-3 suggests a unique mechanism for CCR3 activation.
|
| |
Biochemistry, 39,
12837-12844.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.Blaszczyk,
E.V.Coillie,
P.Proost,
J.V.Damme,
G.Opdenakker,
G.D.Bujacz,
J.M.Wang,
and
X.Ji
(2000).
Complete crystal structure of monocyte chemotactic protein-2, a CC chemokine that interacts with multiple receptors.
|
| |
Biochemistry, 39,
14075-14081.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
K.L.Mayer,
and
M.J.Stone
(2000).
NMR solution structure and receptor peptide binding of the CC chemokine eotaxin-2.
|
| |
Biochemistry, 39,
8382-8395.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
N.Gerber,
H.Lowman,
D.R.Artis,
and
C.Eigenbrot
(2000).
Receptor-binding conformation of the "ELR" motif of IL-8: X-ray structure of the L5C/H33C variant at 2.35 A resolution.
|
| |
Proteins, 38,
361-367.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.C.Liwang,
Z.X.Wang,
Y.Sun,
S.C.Peiper,
and
P.J.Liwang
(1999).
The solution structure of the anti-HIV chemokine vMIP-II.
|
| |
Protein Sci, 8,
2270-2280.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
E.Van Coillie,
J.Van Damme,
and
G.Opdenakker
(1999).
The MCP/eotaxin subfamily of CC chemokines.
|
| |
Cytokine Growth Factor Rev, 10,
61-86.
|
 |
|
|
|
|
 |
M.P.Crump,
L.Spyracopoulos,
P.Lavigne,
K.S.Kim,
I.Clark-lewis,
and
B.D.Sykes
(1999).
Backbone dynamics of the human CC chemokine eotaxin: fast motions, slow motions, and implications for receptor binding.
|
| |
Protein Sci, 8,
2041-2054.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
|